Growing Nottingham

New class of coagulant gets go ahead for clinical

Fri, May 30, 2014 10:49 CET

Haemostatix Ltd announced today that it has received authorisation from the UK regulator, MHRA, to commence a clinical trial of its lead product, PeproStat™. PeproStat is the first of a new class of peptide-based coagulant, or “haemostat”, designed to control bleeding during surgery. Haemostats are used to limit blood loss; to maintain a clear surgical field and to reduce operating time. The leading product on the market is the enzyme thrombin with sales of over $US 1 billion. Thrombin is typically extracted from human donor or bovine blood, and many formulations require preparation

East Midlands Fastest Growing Economy As Nottingham Leads The Way

Thu, May 08, 2014 17:53 CET

The RBS Regional Growth Tracker today named the East Midlands as the fastest growing regional economy, ahead of London, the North West and West Midlands. The East Midlands grew by an estimated 1% in Q1 2014, above the UK-wide figure of 0.8%, with 3.75% more output than this time last year. Nottinghamshire’s conurbations of Nottingham city, north, south and west accounted for a growth of 12.9%. As the only Core City in the region, the ongoing success of Nottingham City Council’s ten year Growth Plan – launched in July 2012 – which includes a range of measures to cut unemployment,

Share

New class of coagulant gets go ahead for clinical

East Midlands Fastest Growing Economy As Nottingham Leads The Way